Toxicokinetics and bioavailability of sulfolane, a ground water contaminant, following oral and intravenous administration in rodents: A dose, species, and sex comparison. 2019

Suramya Waidyanatha, and Sherry R Black, and Timothy R Fennell, and Scott L Watson, and Purvi R Patel, and Stephen D Cooper, and James Blake, and Veronica Godfrey Robinson, and Reshan A Fernando, and Chad R Blystone
Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, United States of America. Electronic address: waidyanathas@niehs.nih.gov.

Sulfolane is a ground water contaminant near refinery sites. The objective of this work was to investigate the toxicokinetics and bioavailability of sulfolane in male and female Harlan Hsd:Sprague Dawley® SD® rats and B6C3F1/N mice following a single oral administration of 10, 30, or 100 mg/kg. Sulfolane was rapidly absorbed in rats with the maximum plasma concentration, Cmax, reached at ≤1.47 h. Although Cmax increased proportionally to the dose, the half-life of elimination increased with the dose and the area under the concentration versus time curve (AUC) increased more than proportionally to the dose. In male and female rats, plasma elimination half-life increased with the dose from 1.97 to 6.33 h. Absorption of sulfolane in mice following oral administration was more rapid than in rats with Cmax reached at ≤0.55 h. In addition, mice had a shorter half-life (≤ 1.25 h) and a lower AUC than rats. In male and female mice, both Cmax and AUC increased more than proportionally to the dose. Bioavailability of sulfolane was higher in rats (81-83%) than mice (59-63%) at 10 mg/kg; at 30 and 100 mg/kg, bioavailability >100% in both species and sexes suggesting that the saturation of metabolism and clearance processes of sulfolane may begin at a single oral dose of ~30 mg/kg. There was no apparent sex difference in toxicokinetic parameters of sulfolane in rats and mice. These data demonstrate that sulfolane was well-absorbed following oral administration with high bioavailability in rats and mice with some species differences, but no sex difference.

UI MeSH Term Description Entries
D008297 Male Males
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D012737 Sex Factors Maleness or femaleness as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or effect of a circumstance. It is used with human or animal concepts but should be differentiated from SEX CHARACTERISTICS, anatomical or physiological manifestations of sex, and from SEX DISTRIBUTION, the number of males and females in given circumstances. Factor, Sex,Factors, Sex,Sex Factor
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species

Related Publications

Suramya Waidyanatha, and Sherry R Black, and Timothy R Fennell, and Scott L Watson, and Purvi R Patel, and Stephen D Cooper, and James Blake, and Veronica Godfrey Robinson, and Reshan A Fernando, and Chad R Blystone
January 2020, Toxicology reports,
Suramya Waidyanatha, and Sherry R Black, and Timothy R Fennell, and Scott L Watson, and Purvi R Patel, and Stephen D Cooper, and James Blake, and Veronica Godfrey Robinson, and Reshan A Fernando, and Chad R Blystone
March 1988, Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao,
Suramya Waidyanatha, and Sherry R Black, and Timothy R Fennell, and Scott L Watson, and Purvi R Patel, and Stephen D Cooper, and James Blake, and Veronica Godfrey Robinson, and Reshan A Fernando, and Chad R Blystone
February 1986, Fundamental and applied toxicology : official journal of the Society of Toxicology,
Suramya Waidyanatha, and Sherry R Black, and Timothy R Fennell, and Scott L Watson, and Purvi R Patel, and Stephen D Cooper, and James Blake, and Veronica Godfrey Robinson, and Reshan A Fernando, and Chad R Blystone
January 2021, Toxicology and applied pharmacology,
Suramya Waidyanatha, and Sherry R Black, and Timothy R Fennell, and Scott L Watson, and Purvi R Patel, and Stephen D Cooper, and James Blake, and Veronica Godfrey Robinson, and Reshan A Fernando, and Chad R Blystone
September 2021, Clinical pharmacology in drug development,
Suramya Waidyanatha, and Sherry R Black, and Timothy R Fennell, and Scott L Watson, and Purvi R Patel, and Stephen D Cooper, and James Blake, and Veronica Godfrey Robinson, and Reshan A Fernando, and Chad R Blystone
July 2021, Xenobiotica; the fate of foreign compounds in biological systems,
Suramya Waidyanatha, and Sherry R Black, and Timothy R Fennell, and Scott L Watson, and Purvi R Patel, and Stephen D Cooper, and James Blake, and Veronica Godfrey Robinson, and Reshan A Fernando, and Chad R Blystone
September 2001, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie,
Suramya Waidyanatha, and Sherry R Black, and Timothy R Fennell, and Scott L Watson, and Purvi R Patel, and Stephen D Cooper, and James Blake, and Veronica Godfrey Robinson, and Reshan A Fernando, and Chad R Blystone
July 2017, Toxicology research,
Suramya Waidyanatha, and Sherry R Black, and Timothy R Fennell, and Scott L Watson, and Purvi R Patel, and Stephen D Cooper, and James Blake, and Veronica Godfrey Robinson, and Reshan A Fernando, and Chad R Blystone
December 1993, Biopharmaceutics & drug disposition,
Suramya Waidyanatha, and Sherry R Black, and Timothy R Fennell, and Scott L Watson, and Purvi R Patel, and Stephen D Cooper, and James Blake, and Veronica Godfrey Robinson, and Reshan A Fernando, and Chad R Blystone
March 2003, Journal of the South African Veterinary Association,
Copied contents to your clipboard!